Phase IIa trial of diphencyprone in patients with viral warts
Phase of Trial: Phase II
Latest Information Update: 22 Jul 2016
At a glance
- Drugs Diphencyprone (Primary)
- Indications Warts
- Focus Proof of concept; Therapeutic Use
- Sponsors Hapten Pharmaceuticals
- 22 Jul 2016 Summary of this trial will be presented at the 2016 Summer Meeting of the American Academy of Dermatology (AAD), according to a RXi Pharmaceuticals media release.
- 07 Jan 2015 New trial record
- 19 Dec 2014 This phase IIa trial has been completed, according to a RXi Pharmaceuticals media release.